SCHEMBL10001941

SCHEMBL10001941

O=C(O)CN(CCN1CCOCCN(CCN(CC(=O)O)CC(=O)O)CCOCC1)CC(=O)O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GLA P06280 1/20 0.56
HSD17B10 Q99714 2/20 0.50
TDP1 Q9NUW8 2/20 0.46
EYA2 O00167 1/20 0.46
APP P05067 1/20 0.46
ACE P12821 1/20 0.46
KDM4E B2RXH2 4/20 0.45
ALOX15 P16050 2/20 0.45
TSHR P16473 2/20 0.45
LMNA P02545 2/20 0.45
CYP2C19 P33261 2/20 0.45
CHRM2 P08172 1/20 0.45
ADRA2A P08913 1/20 0.45
DRD1 P21728 1/20 0.45
SLC6A2 P23975 1/20 0.45
SLC6A4 P31645 1/20 0.45
ADRA1A P35348 1/20 0.45
DRD3 P35462 1/20 0.45
BLM P54132 1/20 0.45
PMP22 Q01453 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18022806 0.86 TDP1 (0.56) GLAHSD17B10TDP1EYA2APP
SCHEMBL16631807 0.86 TDP1 (0.56) GLAHSD17B10TDP1EYA2APP
SCHEMBL15749902 0.83 GLA (0.44) GLAHSD17B10TDP1KDM4EALOX15
Edetic Acid SCHEMBL4266100 0.81 GLA (0.45) GLAHSD17B10TDP1EYA2APP
SCHEMBL1034010 0.80 KDM4E (0.50) GLAHSD17B10KDM4EALOX15TSHR
SCHEMBL18021194 0.79 TDP1 (0.48) HSD17B10TDP1EYA2APPACE
SCHEMBL16631804 0.79 TDP1 (0.48) GLAHSD17B10TDP1EYA2APP
SCHEMBL463091 0.79 TDP1 (0.48) GLAHSD17B10TDP1EYA2APP
SCHEMBL3129632 0.79 TDP1 (0.48) GLAHSD17B10TDP1EYA2APP
SCHEMBL16631806 0.79 TDP1 (0.48) GLAHSD17B10TDP1EYA2APP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8110404-B2 Luminescent lanthanide binding chelates BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2012-02-07 US disclosed
US-8110404-B2 Luminescent lanthanide binding chelates BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2012-02-07 US disclosed
US-20080299675-A1 Luminescent Lanthanide Binding Chelates BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS 2008-12-04 US disclosed
US-20080299675-A1 Luminescent Lanthanide Binding Chelates BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS 2008-12-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080299675-A1 Luminescent Lanthanide Binding Chelates HLCS, LYAR, SLC6A13 GLA 179/4885HSD17B10 4214/4885TDP1 1739/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.